FDA Clears Argus Cognitive's Neurora to Support Autism Diagnosis in Children Ages 18 Months Through 12 YearsArgus Cognitive, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared Neurora (510(k) K260064), a tool that gives clinicians objective behavioral measures to support the diagnosis of autism in children ages 18 months through 12 years.
